Moses 2.0 vs Magneto for HoLEP - a Randomized Controlled Trial (NCT07632742) | Clinical Trial Compass
RecruitingNot Applicable
Moses 2.0 vs Magneto for HoLEP - a Randomized Controlled Trial
United States180 participantsStarted 2026-06
Plain-language summary
The objective of this study is to compare the Magneto 150 holmium laser to the current MOSES 2.0 technology to see if there is a benefit in decreased hemostasis time intraoperatively.
Who can participate
Age range
18 Years – 100 Years
Sex
MALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Undergoing HoLEP for the treatment of bothersome lower urinary tract symptoms
* Internet access and a device to complete postoperative questionnaires (smartphone, tablet, laptop or desktop computer)
Exclusion Criteria:
* Patients who lack decisional capacity
* Patients unable to read/speak English
* Patients who are on a blood thinner (anticoagulation medication)
* Patients who do not have internet access to complete postoperative surveys
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial is comparing two different laser technologies — Moses 2.0 and Magneto — for a prostate procedure called HoLEP, and the main thing they're measuring is how long it takes to stop bleeding during surgery; should I ask my surgeon which of these two laser systems they have the most experience with, and how that might affect my outcome if I'm assigned to one randomly?
2Since this trial isn't assigned a traditional phase like Phase 1 or 2, it seems to be comparing two already-used surgical approaches rather than testing something entirely new — does that mean both options are considered established and safe, or are there still unknowns about one of them that I should be aware of before considering participation?
3HoLEP is a specific surgical technique for an enlarged prostate — is my prostate size, overall health, or any medications I'm on, like blood thinners, likely to affect whether I'd even be a suitable candidate for this kind of trial?
4If I join this trial and I'm randomly assigned to either the Moses 2.0 or Magneto laser, would I still receive what's considered standard-of-care treatment for my BPH, or is there any scenario where my care could differ meaningfully from what you'd recommend outside of a trial?
5Are there other treatment options for my enlarged prostate — like medications, a different surgical approach, or a different laser procedure — that you think I should seriously consider before deciding whether to discuss this trial further with a surgeon?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.